Estudio prospectivo para la detección precoz de carcinoma pulmonar en pacientes con infección por VIH (estudio GESIDA 8815)
Eulalia Valencia, Juan González, Miguel Cervero(Hospital Universitario Severo Ochoa), Francisco Fanjul(Hospital Universitario Son Espases), Inmaculada Jarrín(Instituto de Salud Carlos III), Jorge Vergas(Hospital Clínico San Carlos), María Yllescas(Fundación Seimc-Gesida), Luz Martín‐Carbonero, Antoni A Campins(Hospital Universitario Son Espases), Marta Montero, José Sanz, Delia Romera(Hospital Universitario La Paz), María Jesús Téllez(Hospital Clínico San Carlos), Marta de Miguel(Fundación Seimc-Gesida), Tatiana Pirogova(Hospital Universitario La Paz), Alberto Arranz(Hospital Universitario Príncipe de Asturias), María Tasias(Hospital Universitari i Politècnic La Fe)
Cited by 1
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects
|Journal of Infection|2022|174
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143